Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

被引:0
|
作者
Amanda Hansson-Hedblom
Isabelle Axelsson
Lena Jacobson
Joakim Tedroff
Fredrik Borgström
机构
[1] Quantify Research AB,
[2] Allergan Norden AB,undefined
[3] Neuroenheten Utsikten,undefined
来源
关键词
Migraine; Headache; onabotulinumtoxinA; Botox; Cost-effectiveness; Cost of illness; Burden;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条